COST: new networks in medical and health research

COST is a European network organization where most countries in Europe (including Norway and all EU countries) are members. An important task for COST is to promote European research cooperation by launching scientific networks (“COST actions”).

General information about COST can be found here and here.

In June 2017, it was decided to initiate 35 new COST actions. A list of those relevant to medical and health research is found below.

If you are interested in participating, please contact Hans Hellebostad in the Research Council of Norway by 15 September 2017. (This is not necessarily the last opportunity to participate in the actions, but is set as a first deadline for the Research Council’s follow-up to COST.) You can also get more detailed information about participation in COST. Application form used to participate as a participant can be found here.

In June 2017, it was decided to initiate 35 new COST actions, the following within / relevant to medical and health research:

·        CA16203 – Stem cells of marine/aquatic invertebrates: from basic research to innovative applications (CA16203 – MARISTEM)
·        CA16205 – European Network on Understanding Gastrointestinal Absorption-related Processes (CA16205 – UNGAP)
·        CA16207 – European Network for Problematic Usage of the Internet (CA16207 – EU-PUI)
·        CA16210 – Maximising Impact of research in NeuroDevelopmental DisorderS

(CA16210 – MINDDS)

·        CA16216 – Coordination and Harmonization of European Occupational Cohorts

(CA16216 – OMEGA-NET)

·        CA16217 – European network of multidisciplinary research to improve the urinary stents

(CA16217 – ENIUS)

·        CA16223 – Leukemia Gene Discovery by data sharing, mining and collaboration

(CA16223 – LEGEND)

·        CA16225 – Realising the therapeutic potential of novel cardioprotective therapies


·        CA16226 – Indoor living space improvement: Smart Habitat for the Elderly

(CA16226 – SHELD-ON)

·        CA16227 – Investigation and Mathematical Analysis of Avant-garde Disease Control via Mosquito Nano-Tech-Repellents (CA16227 – IMAAC)
·        CA16231 – European Network of Vaccine Adjuvants (CA16231 – ENOVA)
·        CA16234 – European Cleft and Craniofacial Initiative for Equality in Care (CA16234 – ECCE)

A summary of the actions can be found under the links in brackets. There is also a link for a more detailed description of each operation (Memorandum of Understanding).

Here are the summaries together with some additional information, as well as a complete list of the new COST actions.

The Research Council of Norway coordinates the process for Norwegian participation in COST actions. Hans Hellebostad is the contact person for activities in medicine / health and chemistry.

Leave a Reply

Your email address will not be published. Required fields are marked *